Abstract:Objectives Multiple warfarin pharmacogenetic algorithms have been published and been confirmed to predict warfarin dose more accurately than clinical algorithm or fixed-dose approach. However, their performance in Chinese patients has never been evaluated. We sought to compare the performance of published warfarin pharmacogenetic algorithms in a cohort of Chinese patients under warfarin anticoagulation. Methods The study population consisted of 282 unrelated Han-Chinese patients consecutively admitted to the General Hospital of Chinese People9s Liberation Army between January 2008 and July 2011. The patients had all undergone warfarin anticoagulation for various indications and were stably controlled with a target international normalisation ratio (INR) of 1.6–2.5. Genomic DNA extraction from each patient was followed by genotyping to detect the polymorphisms of CYP2C9*3 (rs1057910), VKORC1 −1639 G/A (rs9923231), and CYP4F2*3 (rs2108622) respectively, using standard techniques. A total of 8 eligible pharmacogenetic algorithms were selected for performance comparison. The performance of each algorithm was evaluated by calculating the percentage of patients whose predicted dose fell within 20% of their actual therapeutic dose (percentage within 20%), and the mean absolute error (MAE) between each predicted dose and actual stable dose. Results In the entire cohort, the pharmacogenetic algorithms could predict warfarin dose with the average MAE of 0.87±0.17 mg/day (0.73–1.17 mg/day), and the average percentage within 20% of 43.8%±8.1% (29.1–52.1%). By pair wise comparison, warfarin dose prediction was significantly more accurate with the algorithms derived from Asian patients (48.6–50.0%) than those from Caucasian patients (29.1–39.7%; OR 1.61–3.36, p≤0.02). Algorithms with additional covariates of INR values or CYP4F2*3 performed better than those without the covariates (adding INR: OR: 1.71 (1.08–2.72), p=0.029; adding CYP4F2*3: OR: 2.67 (1.41–5.05), p=0.004). When the patients were stratified according to the dose range, the algorithms from Caucasian and racially mixed populations tended to perform better in higher dose group (≥4.5 mg/day), and algorithms from Asian populations performed better in intermediate dose group (1.5–4.5 mg/day). None of the algorithms performed well in lower dose group (≤1.5 mg/day). Conclusions Our study indicated that none of the eligible pharmacogenetic algorithms could perform the best for all dosing ranges in the present cohort of Chinese patients under warfarin anticoagulation. It may be important to consider the ethnic and clinical specific characteristics when choosing the appropriate algorithm for a local service population. A more refinement pharmacogenetic algorithm combining 3 genotypes (CYP2C9, VKORC1 and CYP4F2) and clinical factors with INR response could potentially improve the warfarin dose prediction in Chinese patients.

Influence of Ggcx Genotype on Warfarin Dose Requirements in Chinese Patients

The Association Between GGCX, Mir-133 Genetic Polymorphisms and Warfarin Stable Dosage in Han Chinese Patients with Mechanical Heart Valve Replacement.

Genetic factors contribute to patient-specific warfarin dose for Han Chinese.

Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.

Warfarin Dosage Response Related Pharmacogenetics In Chinese Population

The impact of VKORC1-1639G > A genetic polymorphism upon warfarin dose requirement in different ethnic populations.

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

Influence of VKORC1-1639G＞A Genetic Polymorphism on Mean Daily Dose of Warfarin in Asian Populations:A Systematic Review and Meta-analysis

Polymorphisms in the Genes for Coagulation Factor II, V, VII in Patients Undergoing Coronary Angiography

Effect of Multiple Single-Nucleotide Variants in VKORC1 Gene on the Maintenance Doses of Warfarin

Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin

Impact of VKORC1 Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement--a Systematic Review and Meta Analysis.

Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients

Identification of Two Novel Genes SLC15A2 and SLCO1B3 Associated with Maintenance Dose Variability of Warfarin in a Chinese Population

Impact of VKORC1 , CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation

Comparative Performance of Gene-Based Warfarin Dosing Algorithms in Chinese Patients

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

Establishment of clinical drug dosage computation model based on the Warfarin dosage associated genes

Estimation of the Warfarin Dose with A Pharmacogenetic Refinement Algorithm in Chinese Patients Mainly under Low-Intensity Warfarin Anticoagulation

CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.

Comparative performance of pharmacogenetics-based warfarin dosing algorithms in Chinese population: use of a pharmacokinetic/pharmacodynamic model to explore dosing regimen through clinical trial simulation